Autosomal Dominant Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-04-23Clinical Trial Update: Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
An observational study of patients with autosomal dominant polycystic kidney disease sponsored by Otsuka has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 1, Phase 2]
A Phase 1/2 pilot trial evaluated rapamycin (sirolimus) for autosomal dominant polycystic kidney disease; the study completed and results we…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease [NA]
This clinical trial update reports a randomized trial of Triptolide Woldifii for autosomal dominant polycystic kidney disease, which was ter…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 4]
This clinical trial update reports on the efficacy, safety and tolerability of everolimus in preventing end-stage renal disease in autosomal…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control [Phase 2]
A Phase 2 clinical trial is evaluating radiofrequency ablation to control blood pressure and disease progression in autosomal dominant polyc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Somatostatin on ADPKD Heart [Phase 2, Phase 3]
Phase 2/3 trial evaluating somatostatin for heart-related outcomes in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Somatostatin on Liver in ADPKD [Phase 2, Phase 3]
A report on the completion of a Phase 2/3 clinical trial evaluating somatostatin for liver involvement in autosomal dominant polycystic kidn…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
An update on a Phase 3 clinical trial evaluating a triptolide-containing formulation for autosomal dominant polycystic kidney disease (ADPKD…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy [Phase 2, Phase 3]
A clinical trial update summarizing Phase 2/3 results of rapamycin (sirolimus) for autosomal dominant polycystic kidney disease and the use …
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
A Phase 3 trial evaluated sirolimus (Rapamune) for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and the study status is completed.
-
CLINICAL_TRIALS research · 2014-02-14Clinical Trial Update: Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease [NA]
This clinical trial update reports on a study evaluating renal sympathetic denervation as a potential approach to reduce pain and improve in…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety [Phase 2]
Phase 2 trial evaluating sirolimus for renal efficacy and safety in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study [Phase 3]
A completed Phase 3 long-term follow-up study evaluating somatostatin in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency [Phase 2, Phase 3]
A Phase 2/3 study evaluating sirolimus in autosomal dominant polycystic kidney disease with severe renal insufficiency has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Octreotide in Severe Polycystic Liver Disease [Phase 2, Phase 3]
This clinical trial update reports completion and posted results for phase 2/3 studies of octreotide in severe polycystic liver disease, spo…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease
The document reports on a study exploring the relationship between uric acid levels and endothelial dysfunction in patients with autosomal d…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: The Vienna RAP Pilot Study [NA]
The Vienna RAP Pilot Study for autosomal dominant polycystic kidney disease has completed according to the trial record.
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) [NA]
A completed clinical trial from the University of Kansas explored the use of water therapy as a treatment approach for Autosomal Dominant Po…
-
CLINICAL_TRIALS research · 2009-12-02Clinical Trial Update: Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) [Phase 2]
Clinical trial update on a Phase 2 efficacy and safety study for second-line treatment in patients with hypertension associated with autosom…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease [NA]
A clinical trial evaluating adrenal function in autosomal dominant polycystic kidney disease has completed; sponsor is Istanbul University.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Lanreotide as Treatment of Polycystic Livers [Phase 2, Phase 3]
Phase 2/3 clinical trial of lanreotide for polycystic liver disease has completed, indicating ongoing evaluation for this indication.
-
CLINICAL_TRIALS research · 2007-10-18Clinical Trial Update: CCB Safety Study in Treatment of Hypertension of ADPKD [Phase 4]
This entry reports a Phase 4 trial evaluating calcium channel blockers for hypertension in autosomal dominant polycystic kidney disease, wit…
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis [Phase 1]
Phase 1 trial assessing the effects of systemic nitric oxide inhibition on renal hemodynamics in people with autosomal dominant polycystic k…